Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer

NCT01827163 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HER2-Positive Early Stage Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Trastuzumab
DRUG: Lapatinib
DRUG: Pegfilgrastim

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]